CN112236413A - 结晶曲尼司特盐及其药物用途 - Google Patents
结晶曲尼司特盐及其药物用途 Download PDFInfo
- Publication number
- CN112236413A CN112236413A CN201980033248.9A CN201980033248A CN112236413A CN 112236413 A CN112236413 A CN 112236413A CN 201980033248 A CN201980033248 A CN 201980033248A CN 112236413 A CN112236413 A CN 112236413A
- Authority
- CN
- China
- Prior art keywords
- tranilast
- crystalline
- salt
- peaks
- infrared spectrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/68—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862718563P | 2018-08-14 | 2018-08-14 | |
| US62/718,563 | 2018-08-14 | ||
| PCT/EP2019/071881 WO2020035546A1 (en) | 2018-08-14 | 2019-08-14 | Crystalline tranilast salts and their pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112236413A true CN112236413A (zh) | 2021-01-15 |
Family
ID=67997566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980033248.9A Pending CN112236413A (zh) | 2018-08-14 | 2019-08-14 | 结晶曲尼司特盐及其药物用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11078155B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3837238B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7372259B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112236413A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020035546A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11078155B2 (en) * | 2018-08-14 | 2021-08-03 | Nuformix Technologies Limited | Crystalline tranilast salts and their pharmaceutical use |
| US20230146308A1 (en) * | 2020-03-19 | 2023-05-11 | Softhale Nv | Method for the treatment nlrp3-associated diseases |
| AU2022443590A1 (en) | 2022-02-28 | 2024-10-17 | Nuformix Technologies Limited | Compositions and methods for treatment of idiopathic pulmonary fibrosis |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4587356A (en) * | 1981-09-01 | 1986-05-06 | Kissei Pharmaceutical Co., Ltd. | Process for the production of nuclear substituted cinnamoylanthranilic acid derivatives |
| ES8606846A1 (es) * | 1985-07-11 | 1986-05-16 | Uriach & Cia Sa J | Procedimiento de obtencion del acido 2-((3-3,4-dimetoxifenil-1-oxo-2-propenil)amino)benzoico |
| EP0189861A2 (en) * | 1985-01-26 | 1986-08-06 | Showa Denko Kabushiki Kaisha | Percutaneous absorption accelerator for ionic water-soluble medicine |
| US5356620A (en) * | 1989-04-04 | 1994-10-18 | Kissei Pharmaceutical Co. Ltd. | Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid |
| JP2001187728A (ja) * | 1999-12-28 | 2001-07-10 | Lion Corp | 眼科用組成物 |
| JP2005247819A (ja) * | 2003-09-30 | 2005-09-15 | Rohto Pharmaceut Co Ltd | 透明包装体入りトラニラスト含有医薬製剤 |
| JP2006306765A (ja) * | 2005-04-27 | 2006-11-09 | Nippon Tenganyaku Kenkyusho:Kk | トラニラスト水性点眼液 |
| WO2010071865A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| CN104379130A (zh) * | 2012-03-30 | 2015-02-25 | 诺弗米克斯有限公司 | 曲尼司特组合物和共结晶体 |
| KR20180078966A (ko) * | 2016-12-30 | 2018-07-10 | 한국과학기술원 | 진동 감쇠 장치 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5848545B2 (ja) * | 1974-04-18 | 1983-10-28 | キツセイヤクヒンコウギヨウ カブシキガイシヤ | シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ |
| IL150524A0 (en) | 2000-01-07 | 2003-02-12 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| JPWO2007046544A1 (ja) | 2005-10-21 | 2009-04-30 | 株式会社 メドレックス | カルボキシル基を有する肥満細胞脱顆粒抑制剤と有機アミンとの塩を含有する外用剤 |
| US11078155B2 (en) * | 2018-08-14 | 2021-08-03 | Nuformix Technologies Limited | Crystalline tranilast salts and their pharmaceutical use |
-
2019
- 2019-08-14 US US17/051,592 patent/US11078155B2/en active Active
- 2019-08-14 WO PCT/EP2019/071881 patent/WO2020035546A1/en not_active Ceased
- 2019-08-14 CN CN201980033248.9A patent/CN112236413A/zh active Pending
- 2019-08-14 JP JP2020555115A patent/JP7372259B2/ja active Active
- 2019-08-14 EP EP19769990.3A patent/EP3837238B1/en active Active
-
2021
- 2021-07-01 US US17/365,490 patent/US12084399B2/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4587356A (en) * | 1981-09-01 | 1986-05-06 | Kissei Pharmaceutical Co., Ltd. | Process for the production of nuclear substituted cinnamoylanthranilic acid derivatives |
| EP0189861A2 (en) * | 1985-01-26 | 1986-08-06 | Showa Denko Kabushiki Kaisha | Percutaneous absorption accelerator for ionic water-soluble medicine |
| ES8606846A1 (es) * | 1985-07-11 | 1986-05-16 | Uriach & Cia Sa J | Procedimiento de obtencion del acido 2-((3-3,4-dimetoxifenil-1-oxo-2-propenil)amino)benzoico |
| US5356620A (en) * | 1989-04-04 | 1994-10-18 | Kissei Pharmaceutical Co. Ltd. | Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid |
| JP2001187728A (ja) * | 1999-12-28 | 2001-07-10 | Lion Corp | 眼科用組成物 |
| JP2005247819A (ja) * | 2003-09-30 | 2005-09-15 | Rohto Pharmaceut Co Ltd | 透明包装体入りトラニラスト含有医薬製剤 |
| JP2006306765A (ja) * | 2005-04-27 | 2006-11-09 | Nippon Tenganyaku Kenkyusho:Kk | トラニラスト水性点眼液 |
| WO2010071865A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| CN104379130A (zh) * | 2012-03-30 | 2015-02-25 | 诺弗米克斯有限公司 | 曲尼司特组合物和共结晶体 |
| KR20180078966A (ko) * | 2016-12-30 | 2018-07-10 | 한국과학기술원 | 진동 감쇠 장치 |
Non-Patent Citations (2)
| Title |
|---|
| NA GENG ETAL: "Approach of Cocrystallization to Improve the Solubility and Photostability of Tranilast", 《CRYST. GROWTH DES.》 * |
| 曹元华 等: "《中国女性皮肤病学》", 31 December 2009 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3837238B1 (en) | 2024-06-12 |
| EP3837238A1 (en) | 2021-06-23 |
| US20210155577A1 (en) | 2021-05-27 |
| WO2020035546A1 (en) | 2020-02-20 |
| JP2021533080A (ja) | 2021-12-02 |
| US12084399B2 (en) | 2024-09-10 |
| EP3837238C0 (en) | 2024-06-12 |
| JP7372259B2 (ja) | 2023-10-31 |
| US11078155B2 (en) | 2021-08-03 |
| US20210332003A1 (en) | 2021-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10150729B2 (en) | Tranilast compositions and cocrystals | |
| JP2023082086A (ja) | キナーゼ阻害剤化合物の結晶多形、それを含む医薬組成物及びその製造方法と応用 | |
| US12084399B2 (en) | Crystalline tranilast salts and their pharmaceutical use | |
| TWI540131B (zh) | 阿瑞吡坦(aprepitant)l-脯胺酸組成物及共晶體 | |
| JP7453475B2 (ja) | オラパリブシュウ酸共結晶及びその医薬的使用 | |
| US11945814B2 (en) | Salt form | |
| CN118696032A (zh) | 奥拉帕尼羟基苯甲酸共晶体及其药物用途 | |
| US8871793B2 (en) | Metaxalone cocrystals | |
| JP7597771B2 (ja) | 治療のためのベンズアミド共結晶 | |
| HK40049105B (en) | Crystalline tranilast salts and their pharmaceutical use | |
| HK40049105A (en) | Crystalline tranilast salts and their pharmaceutical use | |
| HK1206619B (en) | Tranilast compositions and cocrystals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |